Cargando…

Patient and pathological predictors of management strategy for malignant polyps following polypectomy: a systematic review and meta-analysis

PURPOSE: Malignant polyps present a treatment dilemma for clinicians and patients. This meta-analysis sought to identify the factors that predicted the management strategy for patients diagnosed with a malignant polyp. METHODS: A literature search was performed following the Preferred Reporting Item...

Descripción completa

Detalles Bibliográficos
Autores principales: Zammit, Andrew P., Lyons, Nicholas J., Chatfield, Mark D., Hooper, John D., Brown, Ian, Clark, David A., Riddell, Andrew D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072497/
https://www.ncbi.nlm.nih.gov/pubmed/35394561
http://dx.doi.org/10.1007/s00384-022-04142-6
_version_ 1784701074818465792
author Zammit, Andrew P.
Lyons, Nicholas J.
Chatfield, Mark D.
Hooper, John D.
Brown, Ian
Clark, David A.
Riddell, Andrew D.
author_facet Zammit, Andrew P.
Lyons, Nicholas J.
Chatfield, Mark D.
Hooper, John D.
Brown, Ian
Clark, David A.
Riddell, Andrew D.
author_sort Zammit, Andrew P.
collection PubMed
description PURPOSE: Malignant polyps present a treatment dilemma for clinicians and patients. This meta-analysis sought to identify the factors that predicted the management strategy for patients diagnosed with a malignant polyp. METHODS: A literature search was performed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and the Cochrane Collaboration prognostic studies guidelines. Reports from 1985 onwards were included, data on patient and pathological factors were extracted and random effects meta-analysis models were used. RESULTS: Fifteen studies were included. Seven studies evaluated lymphovascular invasion (LVI). The odds of surgery were significantly higher in malignant polyps with LVI (OR 2.20, 95% CI 1.36–3.55). Ten studies revealed the odds of surgery were significantly higher with positive polypectomy margins (OR 8.09, 95% CI 4.88–13.40). Tumour differentiation was compared in eight studies. There were significantly lower odds of surgery in malignant polyps with well/moderate differentiation compared with poor differentiation (OR 0.31, 95% CI 0.21–0.46). There were non-significant trends favouring surgical resection in younger patients, males and Haggitt 4/Kikuchi Sm3 lesions. There was considerable heterogeneity in the meta-analyses for the variables age, gender, polyp morphology and Haggitt/Kikuchi level (I(2) > 75%). CONCLUSION: This meta-analysis has demonstrated that LVI, positive polypectomy resection margins, and poor tumour differentiation significantly predict malignant polypectomy patients who underwent subsequent surgery. Age and gender were important factors predicting management, but not consistently across studies, whilst polyp morphology and Haggitt/Kikuchi levels did not significantly predict the management strategy. Further research may assist in understanding the management preferences.
format Online
Article
Text
id pubmed-9072497
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-90724972022-05-07 Patient and pathological predictors of management strategy for malignant polyps following polypectomy: a systematic review and meta-analysis Zammit, Andrew P. Lyons, Nicholas J. Chatfield, Mark D. Hooper, John D. Brown, Ian Clark, David A. Riddell, Andrew D. Int J Colorectal Dis Original Article PURPOSE: Malignant polyps present a treatment dilemma for clinicians and patients. This meta-analysis sought to identify the factors that predicted the management strategy for patients diagnosed with a malignant polyp. METHODS: A literature search was performed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and the Cochrane Collaboration prognostic studies guidelines. Reports from 1985 onwards were included, data on patient and pathological factors were extracted and random effects meta-analysis models were used. RESULTS: Fifteen studies were included. Seven studies evaluated lymphovascular invasion (LVI). The odds of surgery were significantly higher in malignant polyps with LVI (OR 2.20, 95% CI 1.36–3.55). Ten studies revealed the odds of surgery were significantly higher with positive polypectomy margins (OR 8.09, 95% CI 4.88–13.40). Tumour differentiation was compared in eight studies. There were significantly lower odds of surgery in malignant polyps with well/moderate differentiation compared with poor differentiation (OR 0.31, 95% CI 0.21–0.46). There were non-significant trends favouring surgical resection in younger patients, males and Haggitt 4/Kikuchi Sm3 lesions. There was considerable heterogeneity in the meta-analyses for the variables age, gender, polyp morphology and Haggitt/Kikuchi level (I(2) > 75%). CONCLUSION: This meta-analysis has demonstrated that LVI, positive polypectomy resection margins, and poor tumour differentiation significantly predict malignant polypectomy patients who underwent subsequent surgery. Age and gender were important factors predicting management, but not consistently across studies, whilst polyp morphology and Haggitt/Kikuchi levels did not significantly predict the management strategy. Further research may assist in understanding the management preferences. Springer Berlin Heidelberg 2022-04-08 2022 /pmc/articles/PMC9072497/ /pubmed/35394561 http://dx.doi.org/10.1007/s00384-022-04142-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Zammit, Andrew P.
Lyons, Nicholas J.
Chatfield, Mark D.
Hooper, John D.
Brown, Ian
Clark, David A.
Riddell, Andrew D.
Patient and pathological predictors of management strategy for malignant polyps following polypectomy: a systematic review and meta-analysis
title Patient and pathological predictors of management strategy for malignant polyps following polypectomy: a systematic review and meta-analysis
title_full Patient and pathological predictors of management strategy for malignant polyps following polypectomy: a systematic review and meta-analysis
title_fullStr Patient and pathological predictors of management strategy for malignant polyps following polypectomy: a systematic review and meta-analysis
title_full_unstemmed Patient and pathological predictors of management strategy for malignant polyps following polypectomy: a systematic review and meta-analysis
title_short Patient and pathological predictors of management strategy for malignant polyps following polypectomy: a systematic review and meta-analysis
title_sort patient and pathological predictors of management strategy for malignant polyps following polypectomy: a systematic review and meta-analysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072497/
https://www.ncbi.nlm.nih.gov/pubmed/35394561
http://dx.doi.org/10.1007/s00384-022-04142-6
work_keys_str_mv AT zammitandrewp patientandpathologicalpredictorsofmanagementstrategyformalignantpolypsfollowingpolypectomyasystematicreviewandmetaanalysis
AT lyonsnicholasj patientandpathologicalpredictorsofmanagementstrategyformalignantpolypsfollowingpolypectomyasystematicreviewandmetaanalysis
AT chatfieldmarkd patientandpathologicalpredictorsofmanagementstrategyformalignantpolypsfollowingpolypectomyasystematicreviewandmetaanalysis
AT hooperjohnd patientandpathologicalpredictorsofmanagementstrategyformalignantpolypsfollowingpolypectomyasystematicreviewandmetaanalysis
AT brownian patientandpathologicalpredictorsofmanagementstrategyformalignantpolypsfollowingpolypectomyasystematicreviewandmetaanalysis
AT clarkdavida patientandpathologicalpredictorsofmanagementstrategyformalignantpolypsfollowingpolypectomyasystematicreviewandmetaanalysis
AT riddellandrewd patientandpathologicalpredictorsofmanagementstrategyformalignantpolypsfollowingpolypectomyasystematicreviewandmetaanalysis